Epitomics Inc.
BiotechnologyUnited States51-200 Employees
Epitomics Inc. is a United States-based biotechnology research company focused on antibody technology. The firm develops their RabMAb platform, a rabbit monoclonal antibody technology designed for use in research, diagnostics, and therapeutics. This proprietary approach emerged from work at Loyola University Chicago and the University of California, San Francisco, and is intended to yield high-quality antibodies for broad applications. The customer base includes researchers and organizations pursuing basic science, diagnostics, and therapeutics development, seeking reliable antibodies for experiments and tool development. The company operates within the biotechnology research industry through its proprietary RabMAb platform, emphasizing antibody quality and cross-domain applicability. Based in the United States, Epitomics is described as part of Abcam, reflecting its integration into a broader ecosystem of antibody research.